Nanorepro AG operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nanorepro AG with three other
miscellaneous service companies in Europe:
Active Biotech AB
sales of 20.20 million Swedish Kronor [US$2.39 million]
Oxford Biodynamics PLC
of the United Kingdom
(£1.18 million [US$1.66 million]
of which 100%
was Pharmaceutical), and
Heidelberg Pharma Ag
(1.90 million Euro [US$2.33 million]
During the year ended December of 2017, sales at
Nanorepro AG were 1.66 million Euro (US$2.04 million).
increase of 7.8%
versus 2016, when the company's sales were 1.54 million Euro.